Cantex Pharmaceuticals, Inc. develops heparin to ameliorate cardiac ischemia-reperfusion injuries. It also develops medications to enhance the safety and effectiveness of existing cancer treatments. The firm provides Disulfiram + copper Chelate that includes non-overlapping cancer stem cell killing mechanisms of actions. The company was founded in 2013 by Thomas P. Kennedy, Neil William Flanzraich and Stephen G. Marcus and is headquartered in Weston, FL.

Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA.

Dow manufactures and sells chemicals, plastic materials, and agricultural services. They deliver products and services to customers in electronics, water, energy, coatings, and agriculture. They specialize in materials science to deliver solutions for customers in packaging, infrastructure, and consumer care.

Lunan Pharmaceutical Group is an Integrated pharmaceutical group, National innovative enterprise and National torch plan key high-tech enterprise that produces, researches and sells both traditional Chinese medicine, chemical medicine and bio-pharmaceutical medicinal products.

Berg is a Swiss private company located in Berg, with subsidiaries in Spain, providing investment services.

ProMetic BioSciences Ltd. operates as a biopharmaceutical company. The company was founded by Christopher Robin Low and is headquartered in Laval, Canada.

Nippon Kayaku produces and retails a range of chemicals. By product category, the company divides itself into four areas. Epoxy resins used as flame retardants in electronics, colorants, and dyes used in inkjet printers and materials for the production of textiles are sold by the functional chemicals segment, which is the one that generates the most income of any segment. Pharmaceutical companies market anti-cancer, biological, cardiovascular, vitamin, and anti-inflammatory medications. The automotive sector is supplied by the safety systems segment with airbag inflators and micro gas generators for seatbelt pre-tensioners, both of which are intended to protect passengers in the event of an accident. Insecticides and herbicides are offered for sale in the agrochemicals market.

Medigreen Biotechnology Corporation, founded on April 10th, 2002, is focusing on the development of botanical new drugs and is established by domestic and overseas outstanding enterprises and entrepreneurs, in accordance with the government's promotion policy, to develop the Chinese Traditional Medicine industry. The major stockholders of Medigreen include Medigen Biotechnology Corp., SunTen Phytotech Co., Ltd. and YFY Biotech Management Company, etc.\nSince the foundation, based on the mission of 'contribution to the human health' and on the main principle of the immunologic system, Medigreen has been worked on the R & D of new botanical drugs on 'cancer adjuvant', 'anti-ulcer' and 'respiratory tract diseases'. Medigreen develops diverse functional products and ingredients on the base of the Traditional Chinese Medicine theory, the concept of 'medicine and food from the same source', and the efficacy examination of biotechnology followed the new drug development process to contribute to the human health and to guarantee the persistent progress of the enterprise during the new drug development.

Beijing Funakang Biotechnology Co., Ltd., established on 2015-02-03, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export;Metal Material Sales;Metal Products Sales;Retailing of computer software, hardware and auxiliary equipment;internet sales(Except for products that require a license for sale);Daily necessities sales;Machinery sales;Sales of building materials;Hardware retail;Food Additive Sales;Cosmetics Retail;Cosmetics Wholesale;food sales(Only sell prepackaged food).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Sichuan Inroadveite Pharmaceutical Technology Co., Ltd., established on 2015-06-18, Business scope includes medical technology research and development;Biotechnology R&D;Food Technology Research and Development;Chemical product development and technology transfer,technical consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of oncology products. The company is currently focusing on developing picoplatin, a new and differentiated platinum-based chemotherapeutic agent that is used in the clinical development for multiple cancer indications, treatment combinations, and by different routes of administration. The company was founded in 1984 and is headquartered in Seattle, WA.

Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

Faron Pharmaceuticals Oy operates as a clinical stage biopharmaceutical company. It develops novel treatments for medical conditions with significant unmet needs caused by dysfunction of immune system. The firm currently has a pipeline based on the receptors involved in regulation of immune response in oncology, organ damage and bone marrow regeneration. Its Bexmarilimab, a novel anti-Clever-1 humanized antibody, is its investigative precision immunotherapy with the potential to provide permanent immune stimulation for difficult-to-treat cancers through targeting myeloid function. The company was founded by Juho Markku Jalkanen, Sirpa Tuulikki Jalkanen, Matti Esa Manner, Juha Peltola, Marko Salmi, Katriina Peltola and Maija-Leena Hollmen in 2003 and is headquartered in Turku, Finland.

IGL Pharma, Inc. provides health care services. The company was founded in 2016 by Keith R. Frank and Jamie Simon and is headquartered in Angleton, TX.

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

Kyoto Biken Laboratories, Inc. manufactures veterinary vaccines. It specializes in bovine, porcine, poultry, and plant vaccines. The firm��s business activities include research and development, manufacturing, laboratory diagnosis for field specimens, quality control, after sales validation, and packaging and shipment. The company was founded in June 1948 and is headquartered in Uji, Japan.

Enzene Biosciences Ltd. is an Indian company located in Pune that manufactures and distributes pharmaceutical reagents. The firm was founded in 2006. Himanshu Gadgil is the current CEO of the company. Enzene Biosciences Ltd. was acquired by Alkem Laboratories Ltd. on January 03, 2012.\nThe company says this about itself: Enzene, a subsidiary of Alkem laboratories Ltd., is an innovation driven biotech company. Enzene's focus lies in producing biosimilars, phytopharmaceuticals and synthetic peptides while venturing into novel biologics.

IDEC Pharmaceuticals develop therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases. Idec Pharmaceuticals was founded in 1986 by UC-San Diego physician and immunologist Ivor Royston, San Diego bioentrepreneur Howard Birndorf, and Stanford University cancer researchers Ron Levy and Richard Miller. In 2003, Idec Pharmaceuticals was merged with Biogen.